Recombinant Horse Insulin (INS), partial - CD BioSciences

service-banner

Recombinant Horse Insulin (INS), partial

Recombinant Horse Insulin (INS), partial

SPP-03087

Size Price
1 mg Online Inquiry
100 μg Online Inquiry
20 μg Online Inquiry
Target Information
Species Equus caballus
Target Name Insulin
UniProt No. P01310
Subcellular Location Secreted
Gene Abbr. INS
Full Name Insulin
Introduction The maintenance of glucose homeostasis is an essential physiological process that is regulated by hormones. An elevation in blood glucose levels during feeding stimulates insulin release from pancreatic β cells through a glucose sensing pathway. Insulin is synthesized as a precursor molecule, proinsulin, which is processed prior to secretion. A- and B-peptides are joined together by a disulfide bond to form insulin, while the central portion of the precursor molecule is cleaved and released as the C-peptide. Insulin stimulates glucose uptake from blood into skeletal muscle and adipose tissue. Insulin deficiency leads to type 1 diabetes mellitus.
Product Details
Product Type Recombinant Protein
Buffer before Lyophilization If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.